Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)].

Bulletin du cancer - 1 Mar 2004

Eisinger François, Bressac Brigitte, Castaigne Damienne, Cottu Pierre-Henri, Lansac Jacques, Lefranc Jean-Pierre, Lesur Anne, Noguès Catherine, Pierret Janine, Puy-Pernias Séverine, Sobol Hagay, Tardivon Anne, Tristant Henri, Villet Richard

Abstract excerpt

BACKGROUND: Since the last recommendations, up to 2,500 new references had been published on that topic. METHODOLOGY: On the behalf of the health Minister, the Ad Hoc Committee consisted of 13 experts carried out a first version revisited by five additional experts who critically analyzed the first version of the report. MAIN UPDATING: Breast and ovarian cancer seem to be associated with fewer deleterious...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diagnostic Imaging
Share to France

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Mastectomy

Share to Ovarian Neoplasms

Share to Ovariectomy

Source

Identifiers

PMID: 15171047

Genes

BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)].PMID 15171047Read ↗

[Identification and management of hereditary breast-ovarian cancers (2004 update)].Semantic proximity Read ↗

[Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers].Semantic proximity Read ↗

[Inserm ad hoc committee: Recommendations for the management of women with a genetic risk for developing cancer of the breast and/or the ovary].Semantic proximity Read ↗

[Gynecological Care and Prevention of Gynecological Malignancies in BRCA1 and BRCA2 Mutation Carriers].Semantic proximity Read ↗

[INSERM-FNCLCC collective expert's report. Recommendations for management of women having a genetic risk of developing breast and/or ovarian cancer. National Federation of Centers of the Fight Against Cancer].Semantic proximity Read ↗

[Hereditary predisposition for the development of breast and ovarian carcinoma].Semantic proximity Read ↗

A systematic review of recommendations on screening strategies for breast cancer due to hereditary predisposition: Who, When, and How?Semantic proximity Read ↗

[Peculiarities of diagnosis, treatment and prevention of hereditary cancer of the breast and ovary. Clinical and genetic screening among BRCA1/2 mutation carriers and individuals with high family risk of cancer].Semantic proximity Read ↗

[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer].Semantic proximity Read ↗

[Guideline for the prevention and early detection of breast and ovarian cancer in high risk patients, particularly in women from HBOC (hereditary breast and ovarian cancer) families].Semantic proximity Read ↗

[Breast and ovarian cancer due to BRCA1&2 hereditary cancer predisposition syndrome and reproduction: literature review].Semantic proximity Read ↗

[Inherited breast and ovarian cancers].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.